What place for pragmatic RCTs in intensive care?

Area of Science:

• Critical Care Medicine
• Clinical Trial Design
• Translational Research

Background:

• Pragmatic trials assess real-world effectiveness, contrasting with explanatory trials that evaluate efficacy under optimal conditions.
• Large-scale academic ICU studies, often pragmatic, frequently fail to show outcome differences compared to controls.
• Patient heterogeneity in ICUs (e.g., sepsis, ARDS) can dilute or mask treatment effects in specific subsets.

Purpose of the Study:

• To discuss challenges in large-scale ICU pragmatic trials.
• To identify reasons for the lack of demonstrated intervention effects in these trials.
• To propose suggestions for improving the performance and outcomes of ICU trials.

Main Methods:

• The article reviews the nature of pragmatic versus explanatory trials.
• It analyzes factors contributing to the failure of ICU intervention studies.
• It discusses suboptimal trial performance, including protocol adherence issues.

Main Results:

• ICU populations exhibit significant inter-individual biological variability, complicating the detection of treatment effects.
• Poor protocol adherence in trials undermines the likelihood of demonstrating benefits, especially with intention-to-treat analyses.
• Existing trial designs may not adequately address the complexities of heterogeneous ICU populations.

Conclusions:

• Heterogeneity and suboptimal trial execution are key barriers to demonstrating intervention effectiveness in ICU pragmatic trials.
• Addressing patient variability and enhancing protocol adherence are critical for future trial success.
• Improvements in trial design and implementation are necessary to yield meaningful results in critical care research.